Stryker Corp
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedStryker Corp (SYK) Multi-Year Return
Stryker Corp — Multi-Year Return
SYK · NYSE · Healthcare
GoodMoat Target
“When a medical device maker trades at nearly 40 times earnings, you're paying champagne prices for what might just be good beer.”
— In the voice of Buffett
What is the Multi-Year Return?
Calculate total returns over 1, 3, 5, and 10-year periods. Understand long-term compounding and investment outcomes.
Key Metrics
Market Cap
$126.79B
P/E Ratio
39.06
Forward P/E
—
EPS
$8.40
PEG Ratio
0.72
Book Value
$58.63
Dividend Yield
1.01%
Profit Margin
12.92%
ROE
14.48%
Multi-Year Return — Data
Pre-loaded data for SYK:
Stryker Corp (SYK) Multi-Year Return
Calculate total returns over 1, 3, 5, and 10-year periods. Understand long-term compounding and investment outcomes.
Stryker Corp is a Healthcare company in the Medical Devices industry, listed on NYSE. Current stock price: $331.54. Market capitalization: $126.79B. EPS: $8.40. P/E ratio: 39.06.
GoodMoat Fair Value target: $206.96. The stock appears 60.2% overvalued based on our blended model.
Use GoodMoat's Multi-Year Return alongside other valuation tools including DCF Calculator, Reverse DCF, Fair Value models, and Quality Score to build a comprehensive investment thesis for Stryker Corp (SYK). All tools are free to use and powered by real-time financial data.